|
1
|
Fink C, Henzler T, Shirinova A, Apfaltrer
P and Wasser K: Thoracic magnetic resonance imaging: Pulmonary
thromboembolism. J Thorac Imaging. 28:171–177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qureshi S, West M and Kirk AJB: Surgical
resection for thymic malignancy. Lung Cancer. 63 (Suppl):S382009.
View Article : Google Scholar
|
|
3
|
Gutschner T, Monika H and Diederichs S:
MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol
Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The Noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y
and Yang K: Up-regulation of long noncoding RNA MALAT1 contributes
to proliferation and metastasis in esophageal squamous cell
carcinoma. J Exp Clin Cancer Res. 34:72015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Wang T, Huang HQ, Li W, Cheng XL
and Yang J: Human MALAT-1 long non-coding RNA is overexpressed in
cervical cancer metastasis and promotes cell proliferation,
invasion and migration. J BUON. 20:1497–1503. 2016.
|
|
8
|
Han Y, Wu Z, Wu T, Huang Y, Cheng Z, Li X,
Sun T, Xie X, Zhou Y and Du Z: Tumor-suppressive function of long
noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and
inactivation of ERK/MAPK signaling. Cell Death Dis. 7:e21232016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Konishi H, Ichikawa D, Yamamoto Y, Arita
T, Shoda K, Hiramoto H, Hamada J, Itoh H, Fujita Y, Komatsu S, et
al: Plasma level of metastasis-associated lung adenocarcinoma
transcript 1 is associated with liver damage and predicts
development of hepatocellular carcinoma. Cancer Sci. 107:149–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Narita M, Narita M, Krizhanovsky V, Nuñez
S, Chicas A, Hearn SA, Myers MP and Lowe SW: A novel role for
high-mobility group a proteins in cellular senescence and
heterochromatin formation. Cell. 126:503–514. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Cello F, Hillion J, Hristov A, Wood LJ,
Mukherjee M, Schuldenfrei A, Kowalski J, Bhattacharya R, Ashfaq R
and Resar LM: HMGA2 participates in transformation in human lung
cancer. Mol Cancer Res. 6:743–750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Malek A, Bakhidze E, Noske A, Sers C,
Aigner A, Schäfer R and Tchernitsa O: HMGA2 gene is a promising
target for ovarian cancer silencing therapy. Int J Cancer.
123:348–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang ML, Chen CC and Chang LC: Gene
expressions of HMGI-C and HMGI(Y) are associated with stage and
metastasis in colorectal cancer. Int J Colorectal Dis.
24:1281–1286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hristov AC, Cope L, Reyes MD, Singh M,
Iacobuzio-Donahue C, Maitra A and Resar LM: HMGA2 protein
expression correlates with lymph node metastasis and increased
tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol.
22:43–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartuma H, Panagopoulos I, Collin A,
Trombetta D, Domanski HA, Mandahl N and Mertens F: Expression
levels of HMGA2 in adipocytic tumors correlate with morphologic and
cytogenetic subgroups. Mol Cancer. 8:362009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TDL: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi D and Zhang Y, Lu R and Zhang Y: The
long non-coding RNA MALAT1 interacted with miR-218 modulates
choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother.
97:543–550. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai RM and Wang CX: Progress of long
non-coding RNA MALAT1 in tumor research. J Clin Oncol.
21:1139–1145. 2016.
|
|
19
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang SH, Zhang WJ, Wu XC, Zhang MD, Weng
MZ, Zhou D, Wang JD and Quan ZW: Long non-coding RNA Malat1
promotes gallbladder cancer development by acting as a molecular
sponge to regulate miR-206. Oncotarget. 7:37857–37867. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang F, Yi F, Han X, Du Q and Liang Z:
MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett.
587:3175–3181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miyagawa R, Tano K, Mizuno R, Nakamura Y,
Ijiri K, Rakwal R, Shibato J, Masuo Y, Mayeda A, Hirose T and
Akimitsu N: Identification of cis- and trans-acting
factors involved in the localization of MALAT-1 noncoding RNA to
nuclear speckles. RNA. 18:738–751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang YJ, Tang XM, Shi MM, Wen CL and Shen
BY: MiR-216a decreases MALAT1 expression, induces G2/M arrest and
apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun.
483:816–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao K, Zhang GJ, Huang ZM and Yao GX:
Expression and function of long non-coding RNA-MALAT1 in liver
cancer. Chin J Gen Surg. 1:90–96. 2016.
|
|
25
|
Kangboonruang K, Wongtrakoongate P,
Lertsuwan K, Khachonkham S, Changkaew P, Tangboonduangjit P,
Siripoon T, Ngamphaiboon N and Chairoungdua A: MALAT1 decreases the
sensitivity of head and neck squamous cell carcinoma cells to
radiation and cisplatin. Anticancer Res. 40:2645–2655. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Li Y, Liu J, Fan Y, Li X, Dong M,
Liu H and Chen J: Expression levels of microRNA-145 and
microRNA-10b are associated with metastasis in non-small cell lung
cancer. Cancer Biol Ther. 17:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ding Y, Zhang C, Zhang J, Zhang N, Li T,
Fang J, Zhang Y, Zuo F, Tao Z, Tang S, et al: miR-145 inhibits
proliferation and migration of breast cancer cells by directly or
indirectly regulating TGF-β1 expression. Int J Oncol. 50:1701–1710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou X, Yue Y, Wang R, Gong B and Duan Z:
MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer
stem cells. Int J Oncol. 50:853–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie SG, Xie YY, Zhang LL and Huang Q:
Effect of miR-145 targeting DAB2 on the migration and invasion of
prostate cancer PC3 cells. Heredity. 36:50–57. 2014.PubMed/NCBI
|
|
31
|
Sun R, Qin C, Jiang B, Fang S, Pan X, Peng
L, Liu Z, Li W, Li Y and Li G: Down-regulation of MALAT1 inhibits
cervical cancer cell invasion and metastasis by inhibition of
epithelial-mesenchymal transition. Mol Biosyst. 12:952–962. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang
G, Gao S, You Z, Zhan C, Liu F and Pang D: Downregulation of long
noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition
via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol.
8:4881–4891. 2015.PubMed/NCBI
|
|
33
|
Rong F, Liu L, Zou C, Zeng J and Xu Y:
MALAT1 promotes cell tumorigenicity through regulating
miR-515-5p/EEF2 axis in non-small cell lung cancer. Cancer Manag
Res. 12:7691–7701. 2020. View Article : Google Scholar : PubMed/NCBI
|
